Diabetic foot infections: A microbiologic review. (May 2022)

• Record Type: Journal Article
• Authors: Hawkins, Brandon K.; Barnard, Marie; Barber, Katie E.; Stover, Kayla R.; Cretella, David A.; Wingler, Mary Joyce B.; Wagner, Jamie L.
• Is Part Of: Foot. Volume 51(2022)
• Publication Date: 2022-05
• Subjects: Antibiotic resistance -- Diabetic foot infections -- Epidemiology -- Pseudomonas aeruginosa -- Staphylococcus aureus; Foot -- Diseases -- Periodicals; Foot -- Surgery -- Periodicals; Foot Diseases -- Periodicals; Foot -- surgery -- Periodicals; Pied -- Maladies -- Périodiques; Pied -- Chirurgie -- Périodiques; Pied -- Lésions et blessures -- Périodiques; Foot -- Diseases; Foot -- Surgery; Periodicals; Electronic journals; Electronic journals; 617.585005
• DOI: 10.1016/j.foot.2021.101877
• Languages: English
• ISSNs: 0958-2592

Abstract

Highlights: Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options. The appropriateness of a single, empiric regimen for all instances of diabetic foot infections (DFIs) is difficult to determine. This review analyzes global literature relating to cultures, incidence, risk factors, resistance, and bacterial distribution in DFIs. S. aureus remains a significant pathogen, with a growing incidence of P. aeruginosa and MDR gram-negative bacilli. Local epidemiology and resistance patterns remain essential for antibiotic treatment considerations. Abstract: Diabetes mellitus continues to be an increasingly common comorbidity. Diabetic foot infections are one of the most common causes of hospitalization in this population, and account for a significant portion of increased hospitalization and healthcare expenditure. Complications, such as osteomyelitis, can necessitate the use of multiple, prolonged antibiotic courses. These courses often consist of broad-spectrum, empiric therapy determined by organisms considered to be commonly associated with these types of infections. Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options. Furthermore, patient specific risk factors can impact the microbiologic diversity found in these infections. As a result, it is difficult to determine if a single empiric regimen is appropriate for all instances of diabetic foot infections. Objectives and methods: This review analyzes global literature relating to the culture methods, incidence, risk factors, resistance patterns, and geographic distribution of the microorganisms isolated from diabetic foot infections using the PRISMA statement for systematic review and meta-analysis reporting. Results: Staphylococcus aureus remains a significant pathogen, with a growing incidence of Pseudomona s aeruginosa and MDR gram-negative bacilli. Conclusions: Though some individualized risk factors can be useful, local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.